Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Research Report 2025

Summary

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

According to APO Research, the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs include Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche and Mylan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.

The report will help the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Company

Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type

5-HT3 Inhibitors
NK1 Inhibitors
Other
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application

Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (2020-2031)
2.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (2020-2031)
2.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Average Price (2020-2031)
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 5-HT3 Inhibitors
2.3.3 NK1 Inhibitors
2.3.4 Other
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Highly Emetogenic Chemotherapy
2.4.3 Moderately Emetogenic Chemotherapy
2.4.4 Low Emetogenic Chemotherapy
2.4.5 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue of Manufacturers (2020-2025)
3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price by Manufacturers (2020-2025)
3.5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Product Type & Application
3.8 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Established Date
3.9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.1.5 Merck Recent Developments
4.2 Eisai
4.2.1 Eisai Company Information
4.2.2 Eisai Business Overview
4.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.2.5 Eisai Recent Developments
4.3 Mundipharma
4.3.1 Mundipharma Company Information
4.3.2 Mundipharma Business Overview
4.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.3.5 Mundipharma Recent Developments
4.4 Qilu Pharma
4.4.1 Qilu Pharma Company Information
4.4.2 Qilu Pharma Business Overview
4.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.4.5 Qilu Pharma Recent Developments
4.5 Teva
4.5.1 Teva Company Information
4.5.2 Teva Business Overview
4.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.5.5 Teva Recent Developments
4.6 Novartis
4.6.1 Novartis Company Information
4.6.2 Novartis Business Overview
4.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.6.5 Novartis Recent Developments
4.7 Heron Therapeutics
4.7.1 Heron Therapeutics Company Information
4.7.2 Heron Therapeutics Business Overview
4.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.7.5 Heron Therapeutics Recent Developments
4.8 Roche
4.8.1 Roche Company Information
4.8.2 Roche Business Overview
4.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.8.5 Roche Recent Developments
4.9 Mylan
4.9.1 Mylan Company Information
4.9.2 Mylan Business Overview
4.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.9.5 Mylan Recent Developments
4.10 Tesaro
4.10.1 Tesaro Company Information
4.10.2 Tesaro Business Overview
4.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.10.5 Tesaro Recent Developments
5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Scenario by Region
5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2020-2031
5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2020-2025
5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2026-2031
5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2020-2031
5.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2020-2025
5.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2026-2031
5.4 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.4.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
5.4.3 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.5.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
5.5.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.6.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
5.6.3 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.7.1 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
5.7.3 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.8.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
5.8.3 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2031)
6.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2031) & (K Units)
6.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2031)
6.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2020-2031)
6.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2020-2031)
6.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2020-2031)
7 Segment by Application
7.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2031)
7.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2031) & (K Units)
7.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2031)
7.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2020-2031)
7.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2020-2031)
7.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain Analysis
8.1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Mode & Process
8.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
8.2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Analyzing Market Dynamics
9.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
9.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Drivers
9.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Opportunities and Challenges
9.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings